How subcortical arousal affects perception
Official title: Shared Subcortical Arousal Systems Across Perceptual Modalities
Run by Yale University · NCT06934356 · Data updated 2026-11-12
This study will test whether activity in deep arousal circuits changes how healthy adults and people with epilepsy (who have thalamic electrodes) perceive sights, sounds, and touch using fMRI, eye measurements, behavioral tests, and direct thalamic recordings and stimulation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years and up |
| Sex | All |
| Enrollment | 202 (estimated) |
| Sponsor | Yale University Academic / other |
| Locations | 8 sites (New Haven, Connecticut and 7 other locations) |
| Status | Recruiting |
| Started | October 13, 2025 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | August 10, 2026 |
| Trial ID | NCT06934356 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults with normal vision and hearing for the healthy cohort (age 18+), and adolescents or adults with epilepsy who already have clinically placed thalamic electrodes (age 13+) for the patient cohort.
✕Probably not a fit
People without normal vision or hearing for accurate eye metrics, pregnant individuals, those with nonremovable ferromagnetic implants (preventing MRI), or people without thalamic electrodes are unlikely to receive direct clinical benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project combines fMRI, eye-tracking (pupil and gaze), behavioral tasks, and direct thalamic recording/stimulation to study how shared subcortical arousal systems influence visual, auditory, and tactile perception. Healthy adult participants will undergo fMRI and eye-metric testing across replicated sessions (auditory and tactile cohorts, N=65 each) and the team will use an existing visual dataset (N=65) for comparison. Analyses will compare brain and eye-metric signatures for perceived versus not-perceived stimuli and will apply machine-learning classification of eye metrics to identify report-independent markers of perception. A separate patient cohort with epilepsy and implanted thalamic electrodes will undergo direct recording and stimulation alongside eye and behavioral measures at participating epilepsy centers.
Why it matters
Potential benefit: If successful, the work could improve understanding of how deep arousal circuits shape perception and point toward better monitoring or targeted interventions for perceptual problems in epilepsy.
How similar studies have gone: Prior fMRI work from this group (including Kronemer et al., 2022) showed robust subcortical signals linked to visual perception, but combining cross-modal fMRI, eye-metric machine-learning, and direct thalamic recording/stimulation across modalities is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
A. The following are the inclusion/exclusion criteria for healthy participants age 18 years and up (Aim 1 and 2): Inclusion: (1) normal vision with or without the use of corrective lenses; (2) normal hearing not needing an assistive hearing device. Exclusion: (1) past history of diagnosis of a psychiatric or neurologic disease; (2) current psychiatric or neurologic disease; (3) requires hard contact lenses or glasses to maintain normal vision (prevents accurate pupil and eye gaze measurements); (4) pregnant or nonremovable ferrous metal objects inside or on the body (prevents MRI). B. The following are the inclusion/exclusion criteria for epilepsy patients with thalamic electrodes age 13 years and up (Aim 3A): Inclusion: (1) normal vision with or without the use of corrective lenses Exclusion: (1) severe vision impairment even with correction preventing ability to see stimuli (prevents accurate pupil and eye gaze measurements); (2) unable to perform the perception task due to cognitive impairment. All participants must be capable of consenting for themselves. C. The following are the inclusion/exclusion criteria for epilepsy patients with thalamic electrodes age 18 year and up (Aim 3B): Inclusion: (1) normal vision with or without the use of corrective lenses; (2) A female subject must have a negative pregnancy test and if sexually active, must be using a reliable form of birth control for the duration of the trial, be surgically sterile, or be at least two years post-menopausal. Exclusion: (1) severe vision impairment even with correction preventing ability to see stimuli (prevents accurate pupil and eye gaze measurements); (2) unable to perform the perception task due to cognitive impairment. All participants must be capable of consenting for themselves; (3) Pregnancy.
Where it's running
-
Yale School of Medicine
New Haven, Connecticut, United States Recruiting -
University of Kansas Medical Center
Kansas City, Kansas, United States Recruiting -
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting -
Mayo Clinic
Rochester, Minnesota, United States Recruiting -
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States Recruiting -
Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting
Show 2 more locations
-
Baylor College of Medicine
Houston, Texas, United States Recruiting -
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States Not yet recruiting
Study contacts
- Principal investigator: Hal Blumenfeld, MD, Phd — Yale University
- Study coordinator: Hal Blumenfeld, MD, PHD
- Email: Hal.blumenfeld@yale.edu
- Phone: (203) 785-3865
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
-
Why People with Epilepsy Get More Infections
This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy
This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Advanced 7T fMRI for brain function in epilepsy and brain injuries
This study tests ultra-high-field brain scans at 7T to see if they can better map brain function in adults with epilepsy or brain lesions and in healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.